Effect of dexamethasone on binding activity of transcription factors nuclear factor-κB and activator protein-1 in SW982 human synovial sarcoma cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 41, Issue 3-4, 2005, Pages 80-82

  Yamazaki, Taisuke ^a   Tukiyama, Takashi ^a   Tokiwa, Takayoshi ^a  

^a Kohno Clinical Medicine Research Institute   (Japan)

Author keywords

Anti inflammatory agent; Cell line; DNA binding assay; Transcription

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL TYPE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SARCOMA CELL; SYNOVIAL SARCOMA; SYNOVIOCYTE;

CELL LINE, TUMOR; DEXAMETHASONE; HUMANS; NF-KAPPA B; SARCOMA, SYNOVIAL; TRANSCRIPTION FACTOR AP-1;

EID: 22344435641     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/0502011.1     Document Type: Article

References (16)

1. Auphan, N.; DiDonato, J. A.; Rossette, C.; Helmberg, A.; Karin, M. Immunosupression by glucocorticoids: inhibition of NK-κB activity through induction of IκB synthesis. Science 270:286-290; 1995.
2. Bondeson, J.; Brennan, F. M.; Foxwell, B. M. J.; Feldmann, M. Effective adenoviral transfer of IκBa into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-κB dependent. J. Rheumatol. 27:2078-2089; 2000.
3. Crofford, L. J.; Tan, B.; McCarthy, C. J.; Hla, T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 40:226-236; 1997.
4. Fini, M. E.; Cook, J. R.; Mohan, R.; Brinckerhoff, C. E. Regulation of matrix metalloproteinase gene expression. In: Parks, W. C.; Mecham, W. C., ed. Matrix metalloproteinase. San Diego, CA: Academic press; 1998: 299-356.
5. Fujisawa, K.; Aono, H.; Hasunuma, T.; Yamamoto, K.; Mita, S.; Nishioka, K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor A. Arthritis Rheum. 31:197-203; 1996.
6. Han, C. W.; Choi, J. H.; Kim, J. M.; Kim, W. Y.; Lee, K. W.; Oh, G. T. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear faclor-kappaB activation induced by tumor necrosis factor alpha. Rheumatology 40:267-273; 2001.
7. Kopp, E.; Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959; 1994.
8. Lehmann, T.; Murphy, C.; Zahra, D.; Handel, M. L. Reduction of tumor necrosis factor induced nuclear factor-κB nuclear translocation and DNA binding by dexamethasone in human osteoarthritic synovial tissue explants. J. Rheumatol. 29:787-795; 2002.
9. Lipsky, P. E. Rheumatoid arthritis. In: Issel bacher, K. J., ed. Harrisons principles of internal medicine. New York: McGraw Hill; 1994:1648-1655.
10. Matsumura, M.; Kakishita, H.; Suzuki, M.; Banba, M.; Hatori, Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci. 69:1067-1077; 2001.
11. Mukaida, N.; Morita, M.; Ishikawa, Y.; Rice, N.; Okamoto, S.; Kasahara, T.; Matsushima, K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289-13295; 1994.
12. Oshimu, H.; Simons, S. S., Jr. Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density. Endocrinology 130:2106-2112; 1992.
13. Sakane, T.; Suzuki, N.; Hirose, N., et al. Mechanisms of KE-298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 24:2213-2220; 1997.
14. Scheimnan, R. I.; Gualberto, A.; Jewell, C. M.; Cidlowski, J. A.; Baldwin, A. S. J. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptor. Mol. Cell Biol. 15:943-958; 1995.
15. Yamazaki, T.; Yokoyama, T.; Akatsu, H.; Tsukiyama, T.; Tokiwa, T. Phenotypic characterization of a human synovial cell line, and its response to dexamethasone. In Vitro Cell. Dev. Biol. 39A:337-339; 2003.
16. Yang, J. P.; Merin, J. P.; Nakano, T. Inhibition of the DNA-binding activity of NK-kappa B by gold compounds in vitro. FEBS Lett. 361:89-96; 1995.